Active Ingredient Tirzepatide (Maximum Dual-Agonist) Dose Strength per Injection 15 mg per single weekly 0.6mL dose Total Content per KwikPen 60 mg Tirzepatide in 2.4 mL solution Primary Manufacturer Eli Lilly and Company Therapeutic Class GIP / GLP-1 Receptor Agonist (Anti-Obesity / Antidiabetic) Administration Route Subcutaneous Injection (Weekly maximum baseline) Supply Timeline 1 Pre-filled Pen (4-week maximum maintenance course)
A person who has reached 160 pounds would maintain at roughly 1,920 to 2,240 calories daily
If you look at a map of the U.S
We serve patients from Langhorne PA, Philadelphia PA, Newtown PA, Levittown PA, Bensalem PA, Yardley PA and surrounding areas, and Bucks County Region
So, it is convenient to travel with this medication if necessary
Individual results vary significantly based on starting weight, dose, lifestyle factors, and genetics